Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
phenylketonurias/obesitat
L'enllaç es desa al porta-retalls
Pàgina 1 des de 46 resultats
The Adolescent Adjustment Profile (AAP) in comparisons of patients with obesity, phenylketonuria or neurobehavioural disorders.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Psychosocial development in children with chronic disease is a key issue in paediatrics. This study investigated whether psychosocial adjustment could be reliably assessed with the 42-item Adolescent Adjustment Profile (AAP) instrument. The study mainly focused on adjustment-to-obesity measurement,
Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Little is known about the consequences of the special energy enriched diet used to treat patients with phenylketonuria (PKU) in terms of obesity and metabolic syndrome (MetSyn) development.
OBJECTIVE
To investigate the prevalence of overweight and obesity, and its consequences in terms of
Overweight in classical phenylketonuria children: A retrospective cohort study.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
High prevalence of overweight and obesity in females with phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The primary treatment for phenylketonuria (PKU) is a low phenylalanine diet together with an amino acid-based, phenylalanine-free formula. Thus, PKU patients tend to consume a diet enriched in carbohydrates which could predispose to obesity. Studies in the 1980s and 1990s demonstrated that
Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 ( LAT1) gene increases the risk of obesity in infants with phenylketonuria
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Purpose: Phenylketonuria (PKU) can be effectively treated with the use of a low-phenylalanine diet. However, some patients become overweight despite proper dietary treatment. We hypothesized that this phenomenon could be explained by the
Is overweight an issue in phenylketonuria?
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Dietary treatment may be associated with an increased risk of obesity in phenylketonuria (PKU). The earliest studies describe a tendency for overweight in PKU, but not all recent publications confirm this, although there are an increasing number of studies describing increased obesity in female
Effects of oral contraceptives and obesity on carrier tests for phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
[Phenylketonuria. Treatment and developmental control].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We evaluated annually the compliance of dietary restriction, weight, height, head circumference EEG and IQ score on 16 children with phenylketonuria comparing the children diagnosed early with those later. The compliance was good in children treated early and bad in the others. Height and head
[Phenylketonuria diagnosed during the neonatal period and breast feeding].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Phenylketonuria (PKU) is due to of a defect in the phenylalanine hydroxylase gene (12q22-24.1) leading to hyperphenylalaninemia. Treatment consists in a low phenylalanine (Phe) diet.
OBJECTIVE
To evaluate the evolution of early diagnosed PKU children, receiving direct breast feeding, and
Recommendations for protein and energy intakes by patients with phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Recent reports describe poor growth in treated children with phenylketonuria (PKU). That poor growth is not a concomitant of the disorder and need not result from therapy is demonstrated by data from the U.S.A. PKU Collaborative Study and from recent data from the U.S.A. In these studies, sufficient
Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
In phenylketonuria, dietary treatment prevents most of the severe brain disease. However, patients have to follow a diet restricted in several natural components, what may cause decreased bone density and obesity. Exercise is known to improve both mental functioning and bone density also
Metabolic syndrome in children and adolescents with phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE
This study aimed to identify markers of metabolic syndrome (MS) in patients with phenylketonuria (PKU).
METHODS
This was a cross-sectional study consisting of 58 PKU patients (ages of 4-15 years): 29 patients with excess weight, and 29 with normal weight. The biochemical variables assessed
Nutritional and metabolic parameters of children and adolescents with phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Evaluation of a phenylalanine-free product for treatment of phenylketonuria.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Ten children with classic phenylketonuria (PKU) participated in a controlled study of a phenylalanine-free formula recently released in the United States (PKU-2). Control data were obtained in the clinic while the children were receiving their baseline formula. The children were given the study
Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Lifelong treatment of phenylketonuria (PKU) includes a phenylalanine (phe) restricted diet that provides sufficient phe for growth and maintenance plus phe-free amino acid formula to meet requirements for protein, energy and micronutrients. Phe tolerance (mg phe/kg body weight/day) is the amount of
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
